Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neurology

• Publication date

  1998-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.50.1.164PMID 9443474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin and insulin-like growth factor receptors in the nervous system

  2008cited by this paper
• Age-related decrease in vulnerability to excitatory amino acids in the nucleus basalis.

  1996cited by this paper
• Discrete brain areas express the insulin-responsive glucose transporter GLUT4.

  1996cited by this paper
• Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease

  1995cited by this paper
• Genetic evidence on modern human origins.

  1995cited by this paper
• Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.

  1995cited by this paper
• Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity--clinical research center study.

  1995cited by this paper
• Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

  1995cited by this paper
• Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study.

  1993cited by this paper
• Alterations in Glucose Metabolism in Patients with Alzheimer's Disease

  1993cited by this paper
• Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain.

  1993cited by this paper
• In sickle disease, unlike wine, dry is not good.

  1993cited by this paper
• Interactions between STDs and HIV infection.

  1992cited by this paper
• Insulin in the brain: a hormonal regulator of energy balance.

  1992cited by this paper
• Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans.

  1992cited by this paper
• Localization of insulin and type 1 IGF receptors in rat brain by in vitro autoradiography and in situ hybridization.

  1991cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• The effects of brainstem peribrachial stimulation on perigeniculate neurons: the blockage of spindle waves.

  1989cited by this paper
• Distribution of insulin receptor-like immunoreactivity in the rat forebrain.

  1989cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Genotyping and sequence analysis of apolipoprotein E isoforms.

  1988cited by this paper
• Analysis of transcription in the archaebacterium Sulfolobus indicates that archaebacterial promoters are homologous to eukaryotic pol II promoters

  1988cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Glutamate: A Neurotransmitter in Mammalian Brain

  1984cited by this paper
• Characterization and Regulation of Insulin Receptors in Rat Brain

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Viral infections and their mitigation in experimental immunosuppression.

  1975cited by this paper

• Acute peripheral versus central inhibition of insulin receptors differentially alters cytokine and blood-brain barrier responses to an inflammatory stimulus.

  2025cites this paper
• Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches

  2025cites this paper
• Intranasal insulin for mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials.

  2025cites this paper
• Optimal Dose of Intranasal Insulin Administration for Reducing Postoperative Delirium Incidence in Older Patients Undergoing Hip Fracture Surgery.

  2025cites this paper
• Therapeutic Effects of Neuro-Cells on Amyloid Pathology, BDNF Levels, and Insulin Signalling in APPswe/PSd1E9 Mice

  2025cites this paper
• Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin Resistance-induced amyloidogenesis

  2025cites this paper
• Shared interactions of six neurotropic viruses with 38 human proteins: a computational and literature-based exploration of viral interactions and hijacking of human proteins in neuropsychiatric disorders

  2025cites this paper
• Defect in Nrf2-Keap-1/ARE-Dependent Redox Signaling in Diabetic Adults in Paving a Path to Alzheimer Disease: A Case–Control Study

  2025cites this paper
• Intranasal Insulin Mitigates Memory Impairment and Neuroinflammation in a Mouse Model of Hippocampal Aging

  2025cites this paper
• Sex-Associated Cerebellar and Hippocampal Volume Reduction in Alzheimer’s Disease: Insights from the Clinical ADNI Cohort and STZ Animal Model

  2025cites this paper
• Role of sacubitril/valsartan in modulating diabetes mediated cognitive and neuronal impairment.

  2025cites this paper
• Insulin Receptor Regulates Neurotrophin and Neurotrophin Receptor Expression in the Differentiation of Neural Stem Cells: In Vitro Study

  2025cites this paper
• Intranasal insulin in Alzheimer disease (diabetes in situ?): a systematic review and meta-analysis

  2025cites this paper
• Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease

  2024cites this paper
• Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia.

  2024cites this paper
• DJ-1-mediated repression of the RNA-binding protein FMRP is predicted to impact known Alzheimer's disease-related protein networks

  2024cites this paper
• Non-canonical Pathways Associated to Amyloid Beta and Tau Protein Dyshomeostasis in Alzheimer's disease: a narrative review.

  2024cites this paper
• The insulin resistant brain: impact on whole-body metabolism and body fat distribution

  2024cites this paper
• Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease

  2024cites this paper
• Epigenetic Alterations in Alzheimer’s Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems

  2024cites this paper
• Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies

  2024cites this paper
• Emerging role of Metformin in Alzheimer's disease: A translational view.

  2024cites this paper
• Insulin and the blood-brain barrier.

  2024cites this paper
• Distribution of insulin in primate brain following nose‐to‐brain transport

  2024cites this paper
• Association among abnormal glycolipids, reproductive hormones, and cognitive dysfunction in female patients with bipolar disorder

  2024cites this paper
• AD-Like Neuropsychiatric Dysfunction in a Mice Model Induced by a Combination of High-Fat Diet and Intraperitoneal Injection of Streptozotocin

  2024cites this paper
• Brain energy metabolism: A roadmap for future research

  2024cites this paper
• Tau suppresses microtubule-regulated pancreatic insulin secretion

  2023cites this paper
• Dementia in Diabetes: The Role of Hypoglycemia

  2023cites this paper
• State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease

  2023cites this paper
• Dietary restriction alters insulin signaling pathway in the brain

  2023cites this paper
• Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.

  2023cites this paper
• Insulin signaling promotes neurogenesis in the brain of adult zebrafish

  2023cites this paper
• Central nervous system insulin signaling can influence the rate of insulin influx into brain

  2023cites this paper
• Safety and efficacy of intranasal insulin in patients with Alzheimer’s disease: a systematic review and meta-analysis

  2023cites this paper
• Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan

  2023cites this paper
• Mapping the evolution of inhaled drug delivery research: Trends, collaborations, and emerging frontiers.

  2023cites this paper
• Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia

  2023cites this paper
• Evidence for an alternative insulin transporter at the blood-brain barrier.

  2022cites this paper
• Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau

  2022cites this paper
• Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease

  2022cites this paper
• Association of long‐term hyperglycaemia and insulin resistance with brain atrophy and cognitive decline: A longitudinal cohort study

  2022cites this paper
• Impaired insulin signalling and allostatic load in Alzheimer disease

  2022cites this paper
• Brain Metabolic Alterations in Alzheimer’s Disease

  2022cites this paper
• Efficacy of Glucose Metabolism-Related Indexes on the Risk and Severity of Alzheimer’s Disease: A Meta-Analysis

  2022cites this paper
• Secreted decoy of insulin receptor is required for blood-brain and blood-retina barrier integrity in Drosophila

  2022cites this paper
• Insulin blood-brain barrier transport and interactions are greater following exercise in mice.

  2022cites this paper
• Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease

  2022cites this paper
• A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro

  2022cites this paper
• Early-Life Environment Influence on Late-Onset Alzheimer’s Disease

  2022cites this paper
• Vitamin K dietary intake is associated with cognitive function in an older adult Mediterranean population.

  2022cites this paper
• Design, Synthesis, and Preliminary Evaluation of [68Ga]Ga-NOTA-Insulin as a PET Probe in an Alzheimer’s Disease Mouse Model

  2022cites this paper
• Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease

  2022cites this paper
• Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics

  2022cites this paper
• Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review

  2022cites this paper
• Evidence for preserved insulin responsiveness in the aging rat brain

  2022cites this paper
• The influence of insulin on anticipation and consummatory reward to food intake: A functional imaging study on healthy normal weight and overweight subjects employing intranasal insulin delivery

  2022cites this paper
• Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development

  2022cites this paper
• Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites

  2022cites this paper
• Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

  2022cites this paper
• Insulin action in the brain: cell types, circuits, and diseases.

  2022cites this paper
• Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration

  2022cites this paper
• The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity

  2022cites this paper
• The differentially expressed proteins related to clinical viral encephalitis revealed by proteomics

  2022cites this paper
• Insulin Docking Within the Open Hemichannel of Connexin 43 May Reduce Risk of Amyotrophic Lateral Sclerosis

  2022cites this paper
• Amyloid β-Peptide Effects on Glucose Regulation Are Dependent on Apolipoprotein E Genotype

  2022cites this paper
• Effect of Selenium Treatment on Central Insulin Sensitivity: A Proteomic Analysis in β-Amyloid Precursor Protein/Presenilin-1 Transgenic Mice

  2022cites this paper
• Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development

  2022cites this paper
• The TgF344-AD rat: behavioral and proteomic changes associated with aging and protein expression in a transgenic rat model of Alzheimer's disease.

  2022cites this paper
• Intranasal insulin

  2021cites this paper
• Therapies for Alzheimer's disease: a metabolic perspective.

  2021cites this paper
• Preventing Dementia? Interventional Approaches in Mild Cognitive Impairment.

  2021cites this paper
• Targeting Insulin Resistance to Treat Cognitive Dysfunction

  2021cites this paper
• Intranasal drug delivery: opportunities and toxicologic challenges during drug development

  2021cites this paper
• Insulin on the brain: The role of central insulin signalling in energy and glucose homeostasis

  2021cites this paper
• Intranasal Insulin for Alzheimer’s Disease

  2021cites this paper
• Experimental Approach to Alzheimer’s Disease with Emphasis on Insulin Resistance in the Brain

  2021cites this paper
• The imbalance of PGD2-DPs pathway is involved in the type 2 diabetes brain injury by regulating autophagy

  2021cites this paper
• Metabolic determinants of Alzheimer's disease: a focus on thermoregulation.

  2021cites this paper
• De la régulation nerveuse de l’insulino-sécrétion au rôle de l’insuline sur le cerveau. Les multiples travaux pionniers de Daniel Porte Jr. (1931–2020)

  2021cites this paper
• Effects of apolipoprotein E isoform, sex, and diet on insulin BBB pharmacokinetics in mice

  2021cites this paper
• Metabolic Syndrome: Is It Time to Add the Central Nervous System?

  2021cites this paper
• Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms

  2021cites this paper
• Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue

  2021cites this paper
• The crosstalk between brain and periphery: Implications for brain health and disease.

  2021cites this paper
• Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease

  2021cites this paper
• Influence of selected drugs used in the treatment of type 2 diabetes and cardiovascular diseases on depressive disorders in elderly patients

  2021cites this paper
• A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice

  2021cites this paper
• The brain as an insulin-sensitive metabolic organ

  2021cites this paper
• Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling

  2021cites this paper
• Intranasal administration of 40 and 80 units of insulin does not cause hypoglycemia during cardiac surgery: a randomized controlled trial

  2021cites this paper
• Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links

  2021cites this paper
• Breakdown of the blood–brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?

  2021cites this paper
• Lower insulin secretion is associated with hippocampal and parahippocampal gyrus atrophy in elderly patients with type 2 diabetes mellitus

  2021cites this paper
• Insulin BBB pharmacokinetics in young apoE male and female transgenic mice

  2020cites this paper
• Brain insulin circuit. From the basics to impact on the clinic.

  2020cites this paper
• Inhibitory Activity of Insulin on Aβ Aggregation Is Restricted Due to Binding Selectivity and Specificity to Polymorphic Aβ States

  2020cites this paper
• Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.

  2020cites this paper
• Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway

  2020cites this paper
• Type 2 Diabetes Mellitus Management in Older Adults with Dementia

  2020cites this paper